Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

Hyeyoon Chang, Jung Sun Kim, Yoon Ji Choi, Jae Gu Cho, Jeong Soo Woo, Aeree Kim, Jun Suk Kim, Eun Joo Kang

    Research output: Contribution to journalArticlepeer-review

    50 Citations (Scopus)

    Abstract

    Objectives: PD-1/PD-L1 and CTLA-4 have been investigated and are thought to play an important role in tumor evasion. This study aimed to investigate expression patterns of immune-related molecules, and their clinical impacts in malignant salivary gland tumors. Patients and methods: We performed immunohistochemical staining for PD-L1, PD-L2, CTLA-4, PD-1, and CD8+ tumor-infiltrating lymphocytes in 70 malignant salivary gland tumors. Protein expression was assessed by H-score by multiplying the staining intensity by the percentage of cells with positive staining. Results: The tumors comprised mucoepidermoid carcinomas (38.6%), adenoid cystic carcinomas (21.4%), salivary duct carcinomas (15.7%), and others. In malignant salivary gland tumors, PD-L2 expression was high, while expression of PD-L1 was relatively low in terms of the percentage of positively stained cells and the staining intensity. In univariate analysis, PD-L2 expression (H-score,1 vs ≥1), PD-1 (H-score,1 vs ≥1), and CD8+ tumor-infiltrating lymphocytes (H-score,1 vs ≥1) were significant prognostic factors. In multivariate analysis, low PD-L2 expression (H-score,1) was independently associated with shorter relapse-free survival (hazard ratio =6.514; 95% confidence interval, 1.2-36.2; P=0.032). Conclusion: In summary, PD-L2 is potentially an important biomarker in malignant salivary gland tumors, especially in regard to relapse.

    Original languageEnglish
    Pages (from-to)2983-2992
    Number of pages10
    JournalOncoTargets and Therapy
    Volume10
    DOIs
    Publication statusPublished - 2017 Jun 13

    Bibliographical note

    Publisher Copyright:
    © 2017 Chang et al.

    Keywords

    • CTLA-4
    • Malignant salivary gland tumors
    • PD-L1
    • PD-L2
    • Relapse-free survival
    • Tumor-infiltrating lymphocytes

    ASJC Scopus subject areas

    • Oncology
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors'. Together they form a unique fingerprint.

    Cite this